• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

模拟放射性标记超液态碘油和微球对各种β发射体的生物学效应:基于VX2肿瘤的研究

Biological efficacy of simulated radiolabeled Lipiodol® ultra-fluid and microspheres for various beta emitters: study based on VX2 tumors.

作者信息

Dieudonné Arnaud, Becker Stéphanie, Soares Miguel, Hollenbeck Claire, De Goltstein Marie-Christine, Vera Pierre, Santus Robin

机构信息

Nuclear Medicine Department, Henri Becquerel Cancer Center, 76000, Rouen, France.

QuantIF-LITIS EA4108, University of Rouen, Rouen, France.

出版信息

EJNMMI Res. 2023 Nov 23;13(1):101. doi: 10.1186/s13550-023-01051-9.

DOI:10.1186/s13550-023-01051-9
PMID:37995042
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10667182/
Abstract

BACKGROUND

Radioembolization is one therapeutic option for the treatment of locally early-stage hepatocellular carcinoma. The aim of this study was to evaluate the distribution of Lipiodol® ultra-fluid and microspheres and to simulate their effectiveness with different beta emitters (Y, Re, P, Ho, I, and Lu) on VX2 tumors implanted in the liver of 30 New Zealand rabbits.

RESULTS

Twenty-three out of 30 rabbits had exploitable data: 14 in the group that received Lipiodol® ultra-fluid (group L), 6 in the group that received microspheres (group M), and 3 in the control group (group C). The histologic analysis showed that the Lipiodol® ultra-fluid distributes homogeneously in the tumor up to 12 days after injection. The X-ray μCT images showed that Lipiodol® ultra-fluid has a more distal penetration in the tumor than microspheres. The entropy (disorder of the system) in the L group was significantly higher than in the M group (4.06 vs 2.67, p = 0.01). Equivalent uniform biological effective doses (EUBED) for a tumor-absorbed dose of 100 Gy were greater in the L group but without statistical significance except for Lu (p = 0.03). The radionuclides ranking by EUBED (from high to low) was Y, Re, P, Ho, I, and Lu.

CONCLUSIONS

This study showed a higher ability of Lipiodol® ultra-fluid to penetrate the tumor that translated into a higher EUBED. This study confirms Y as a good candidate for radioembolization, although P, Ho, and Re can achieve similar results.

摘要

背景

放射性栓塞是治疗局部早期肝细胞癌的一种治疗选择。本研究的目的是评估超液态碘化油和微球的分布情况,并模拟它们与不同β发射体(钇、铼、磷、钬、碘和镥)对植入30只新西兰兔肝脏的VX2肿瘤的有效性。

结果

30只兔子中有23只获得了可利用的数据:接受超液态碘化油的组(L组)有14只,接受微球的组(M组)有6只,对照组(C组)有3只。组织学分析表明,超液态碘化油在注射后12天内均匀分布于肿瘤中。X射线μCT图像显示,超液态碘化油在肿瘤中的穿透深度比微球更深。L组的熵(系统无序度)显著高于M组(4.06对2.67,p = 0.01)。肿瘤吸收剂量为100 Gy时,L组的等效均匀生物有效剂量(EUBED)更大,但除镥外无统计学意义(p = 0.03)。按EUBED(从高到低)排列的放射性核素顺序为钇、铼、磷、钬、碘和镥。

结论

本研究表明超液态碘化油穿透肿瘤的能力更强,这转化为更高的EUBED。本研究证实钇是放射性栓塞的良好候选者,尽管磷、钬和铼也能取得类似结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2249/10667182/8a23ab570410/13550_2023_1051_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2249/10667182/001265b86dad/13550_2023_1051_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2249/10667182/b59625a80ee2/13550_2023_1051_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2249/10667182/3b789be1fc34/13550_2023_1051_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2249/10667182/92ad9feba173/13550_2023_1051_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2249/10667182/1f952ce2c023/13550_2023_1051_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2249/10667182/0b242f7749e3/13550_2023_1051_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2249/10667182/8a23ab570410/13550_2023_1051_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2249/10667182/001265b86dad/13550_2023_1051_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2249/10667182/b59625a80ee2/13550_2023_1051_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2249/10667182/3b789be1fc34/13550_2023_1051_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2249/10667182/92ad9feba173/13550_2023_1051_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2249/10667182/1f952ce2c023/13550_2023_1051_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2249/10667182/0b242f7749e3/13550_2023_1051_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2249/10667182/8a23ab570410/13550_2023_1051_Fig7_HTML.jpg

相似文献

1
Biological efficacy of simulated radiolabeled Lipiodol® ultra-fluid and microspheres for various beta emitters: study based on VX2 tumors.模拟放射性标记超液态碘油和微球对各种β发射体的生物学效应:基于VX2肿瘤的研究
EJNMMI Res. 2023 Nov 23;13(1):101. doi: 10.1186/s13550-023-01051-9.
2
Biodistribution, pharmacokinetics, and organ-level dosimetry for Re-AHDD-Lipiodol radioembolization based on quantitative post-treatment SPECT/CT scans.基于治疗后定量SPECT/CT扫描的Re-AHDD-碘油放射性栓塞的生物分布、药代动力学和器官水平剂量测定。
EJNMMI Phys. 2018 Dec 7;5(1):30. doi: 10.1186/s40658-018-0227-6.
3
Heated lipiodol as an embolization agent for transhepatic arterial embolization in VX2 rabbit liver cancer model.加热的碘油作为栓塞剂在 VX2 兔肝癌模型中的经肝动脉栓塞。
Eur J Radiol. 2010 Feb;73(2):412-9. doi: 10.1016/j.ejrad.2008.11.001. Epub 2008 Dec 16.
4
Radioembolization of hepatocarcinoma with (90)Y glass microspheres: development of an individualized treatment planning strategy based on dosimetry and radiobiology.用(90)Y玻璃微球进行肝癌的放射性栓塞:基于剂量学和放射生物学制定个体化治疗计划策略
Eur J Nucl Med Mol Imaging. 2015 Oct;42(11):1718-1738. doi: 10.1007/s00259-015-3068-8. Epub 2015 Jun 27.
5
Theranostic application of lipiodol for transarterial chemoembolization in a VX2 rabbit liver tumor model.载药微球经肝动脉化疗栓塞治疗兔 VX2 肝癌模型的治疗与诊断应用。
Theranostics. 2019 May 27;9(13):3674-3686. doi: 10.7150/thno.32943. eCollection 2019.
6
Evaluation of the pharmacokinetics, dosimetry, and therapeutic efficacy for the α-particle-emitting transarterial radioembolization (αTARE) agent [Ac]Ac-DOTA-TDA-Lipiodol against hepatic tumors.评估发射α粒子的经动脉放射性栓塞(αTARE)剂[Ac]Ac-DOTA-TDA-碘油对肝肿瘤的药代动力学、剂量学和治疗效果。
EJNMMI Radiopharm Chem. 2023 Aug 14;8(1):19. doi: 10.1186/s41181-023-00205-3.
7
Improving MRI-based dosimetry for holmium-166 transarterial radioembolization using a nonrigid image registration for voxelwise calculation.使用非刚性图像配准进行体素计算,提高钬-166 经动脉放射性栓塞的 MRI 剂量学。
Med Phys. 2023 Feb;50(2):935-946. doi: 10.1002/mp.16014. Epub 2022 Oct 24.
8
Changes of tumor microcirculation after transcatheter arterial chemoembolization: first pass perfusion MR imaging and Chinese ink casting in a rabbit model.经导管动脉化疗栓塞术后肿瘤微循环的变化:兔模型中的首过灌注磁共振成像及墨汁灌注法
World J Gastroenterol. 2004 May 15;10(10):1415-20. doi: 10.3748/wjg.v10.i10.1415.
9
Lipiodol solution of 188Re-HDD as a new therapeutic agent for transhepatic arterial embolization in liver cancer: preclinical study in a rabbit liver cancer model.188Re-HDD碘油溶液作为肝癌经肝动脉栓塞的新型治疗剂:兔肝癌模型的临床前研究
J Nucl Med. 2003 Dec;44(12):2033-8.
10
[Expression of MT1-MMP and its significance in rabbit VX2 tumor tissues after transarterial embolization with hydroxyapatite nanoparticles].[羟基磷灰石纳米粒经动脉栓塞后MT1-MMP在兔VX2肿瘤组织中的表达及其意义]
Zhonghua Wai Ke Za Zhi. 2008 Apr 15;46(8):606-9.

引用本文的文献

1
[Y]Y-L4-Lipo/ ethyl esters of Iodized fatty acids of poppy seed oil (lipiodol ultra-fluid), a new TARE formulation, designed from a lipophilic ligand for stability and safety.[Y]罂粟籽油(超液态碘化油)碘脂肪酸的Y-L4-脂质/乙酯,一种新的经动脉放射性栓塞治疗(TARE)制剂,由亲脂性配体制成,以确保稳定性和安全性。
EJNMMI Radiopharm Chem. 2025 Jun 10;10(1):29. doi: 10.1186/s41181-025-00352-9.

本文引用的文献

1
Animal Models of Hepatocellular Carcinoma for Local-Regional Intraarterial Therapies.用于局部区域性肝动脉治疗的肝细胞癌动物模型。
Radiol Imaging Cancer. 2022 Jul;4(4):e210098. doi: 10.1148/rycan.210098.
2
Rabbit VX2 Liver Tumor Model: A Review of Clinical, Biology, Histology, and Tumor Microenvironment Characteristics.兔VX2肝肿瘤模型:临床、生物学、组织学及肿瘤微环境特征综述
Front Oncol. 2022 May 10;12:871829. doi: 10.3389/fonc.2022.871829. eCollection 2022.
3
Radioembolization of Hepatocellular Carcinoma with Y Glass Microspheres: No Advantage of Voxel Dosimetry with Respect to Mean Dose in Dose-Response Analysis with Two Radiological Methods.
用钇玻璃微球进行肝细胞癌的放射性栓塞:在两种放射学方法的剂量反应分析中,体素剂量测定相对于平均剂量无优势。
Cancers (Basel). 2022 Feb 15;14(4):959. doi: 10.3390/cancers14040959.
4
EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds.EANM 实践指南:经动脉放射性化合物治疗肝癌和肝转移瘤。
Eur J Nucl Med Mol Imaging. 2022 Apr;49(5):1682-1699. doi: 10.1007/s00259-021-05600-z. Epub 2022 Feb 11.
5
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update.BCLC 策略用于预后预测和治疗推荐:2022 年更新版。
J Hepatol. 2022 Mar;76(3):681-693. doi: 10.1016/j.jhep.2021.11.018. Epub 2021 Nov 19.
6
Accurate non-tumoral 99mTc-MAA absorbed dose prediction to plan optimized activities in liver radioembolization using resin microspheres.使用树脂微球进行肝动脉栓塞放射治疗时,准确预测非肿瘤性 99mTc-MAA 吸收剂量以规划优化的活动。
Phys Med. 2021 Sep;89:250-257. doi: 10.1016/j.ejmp.2021.07.032. Epub 2021 Aug 23.
7
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
8
The number of microspheres in Y90 radioembolization directly affects normal tissue radiation exposure.钇-90放射性栓塞治疗中微球的数量直接影响正常组织的辐射暴露。
Eur J Nucl Med Mol Imaging. 2020 Apr;47(4):816-827. doi: 10.1007/s00259-019-04588-x. Epub 2019 Nov 18.
9
Transarterial Radioembolization (TARE) Agents beyond Y-Microspheres.经动脉放射性栓塞(TARE)药物除 Y 微球之外。
Biomed Res Int. 2018 Dec 31;2018:1435302. doi: 10.1155/2018/1435302. eCollection 2018.
10
The alfa and beta of tumours: a review of parameters of the linear-quadratic model, derived from clinical radiotherapy studies.肿瘤的阿尔法和贝塔:从临床放射治疗研究中得出的线性二次模型参数综述。
Radiat Oncol. 2018 May 16;13(1):96. doi: 10.1186/s13014-018-1040-z.